Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and Nodal

Jonathan A. Kelber(Baylor University), Peter C. Gray(iMinds)

Journal of Biological Chemistry

December 19, 2007

10.1074/jbc.m704960200

Cited by 67

Related Papers

A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers

|Oncogene|2021|30

Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance

|bioRxiv (Cold Spring Harbor Laboratory)|2023|4

Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survival

|Biochemical and Biophysical Research Communications|2024|2

Abstract 2140: Mesenchymal stromal cells expressing a PEAK1/Cripto axis sustain pro-survival NF-κB signaling in adjacent tumor cells to promote disease progression and therapy resistance

|Cancer Research|2018|0